Skandinaviska Enskilda Banken (SEB)’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-28,000
| Closed | -$2.84M | – | 349 |
|
|
2025
Q4 | $2.84M | Sell |
28,000
-304,136
| -92% | -$24.4M | 0.01% | 519 |
|
|
2025
Q3 | $18.2M | Sell |
332,136
-44
| -0% | -$2.2K | 0.07% | 198 |
|
|
2025
Q2 | $17.6M | Sell |
332,180
-37,549
| -10% | -$1.91M | 0.08% | 208 |
|
|
2025
Q1 | $16M | Hold |
369,729
| – | – | 0.08% | 205 |
|
|
2024
Q4 | $20.8M | Hold |
369,729
| – | – | 0.09% | 171 |
|
|
2024
Q3 | $25.2M | Hold |
369,729
| – | – | 0.12% | 148 |
|
|
2024
Q2 | $15.6M | Buy |
369,729
+93
| +0% | +$5.12K | 0.08% | 202 |
|
|
2024
Q1 | $25.5M | Sell |
369,636
-61,631
| -14% | -$3.9M | 0.12% | 152 |
|
|
2023
Q4 | $31.9M | Buy |
431,267
+197,600
| +85% | +$13M | 0.18% | 107 |
|
|
2023
Q3 | $15.9M | Buy |
233,667
+199,222
| +578% | +$16.9M | 0.1% | 183 |
|
|
2023
Q2 | $3.23M | Buy |
34,445
+3,102
| +10% | +$242K | 0.02% | 446 |
|
|
2023
Q1 | $2.13M | Buy |
31,343
+54
| +0.2% | +$3.47K | 0.01% | 540 |
|
|
2022
Q4 | $1.55M | Buy |
31,289
+358
| +1% | +$14.6K | 0.01% | 595 |
|
|
2022
Q3 | $1M | Sell |
30,931
-10,314
| -25% | -$425K | 0.01% | 681 |
|
|
2022
Q2 | $1.63M | Buy |
41,245
+3,258
| +9% | +$174K | 0.01% | 625 |
|
|
2022
Q1 | $2.66M | Sell |
37,987
-6,084
| -14% | -$445K | 0.02% | 557 |
|
|
2021
Q4 | $3.43M | Sell |
44,071
-64,600
| -59% | -$5.7M | 0.02% | 508 |
|
|
2021
Q3 | $10.4M | Sell |
108,671
-86,006
| -44% | -$9.08M | 0.06% | 283 |
|
|
2021
Q2 | $24.2M | Buy |
194,677
+61,662
| +46% | +$7.36M | 0.15% | 149 |
|
|
2021
Q1 | $17.5M | Buy |
133,015
+91,655
| +222% | +$12.5M | 0.12% | 174 |
|
|
2020
Q4 | $5.48M | Buy |
41,360
+3,180
| +8% | +$385K | 0.04% | 347 |
|
|
2020
Q3 | $3.89M | Buy |
38,180
+15,112
| +66% | +$1.31M | 0.03% | 387 |
|
|
2020
Q2 | $2.01M | Buy |
23,068
+4,668
| +25% | +$373K | 0.02% | 560 |
|
|
2020
Q1 | $1.07M | Sell |
18,400
-20,989
| -53% | -$1.7M | 0.01% | 638 |
|
|
2019
Q4 | $3.64M | Buy |
39,389
+21,889
| +125% | +$1.92M | 0.03% | 413 |
|
|
2019
Q3 | $1.58M | Buy |
17,500
+2,700
| +18% | +$308K | 0.01% | 602 |
|
|
2019
Q2 | $1.75M | Buy |
+14,800
| New | +$1.49M | 0.02% | 553 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Skandinaviska Enskilda Banken (SEB)'s EXAS Position: Q1 2026 in Review
Skandinaviska Enskilda Banken (SEB) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 28,000 shares — an estimated $2.84M sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in EXAS in Q2 2019 and held it in 27 quarters. The position peaked at $31.9M in Q4 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Skandinaviska Enskilda Banken (SEB) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 28,000 Exact Sciences shares in Q1 2026, an estimated $2.84M.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Exact Sciences in Q2 2019 and held it in 27 quarters.
- Skandinaviska Enskilda Banken (SEB)'s Exact Sciences position peaked at $31.9M in Q4 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.